NCT02342626View on ClinicalTrials.gov

Devel. and Eval. of an Active Surveillance Decision Aid for Men With Low or Intermediate Grade Prostate Cancer

NACompletedINTERVENTIONAL
Enrollment

140

Participants

Timeline

Start Date

January 31, 2015

Primary Completion Date

November 30, 2017

Study Completion Date

December 31, 2017

Conditions
Adenocarcinoma of Prostate
Interventions
BEHAVIORAL

Dashboard

With the health care provider, subjects will use the decision dashboard to augment the discussion of treatment options.

Trial Locations (1)

14642

University of Rochester Medical Center, Rochester

All Listed Sponsors
lead

University of Rochester

OTHER

NCT02342626 - Devel. and Eval. of an Active Surveillance Decision Aid for Men With Low or Intermediate Grade Prostate Cancer | Biotech Hunter | Biotech Hunter